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Stromal Cells Direct Local Differentiation
of Regulatory Dendritic Cells
have distinct roles in immunity (den Haan et al., 2000;
Maldonado-Lopez et al., 1999; Pulendran et al., 1999).
Whereas some studies indicate that each subset has
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London School of Hygiene and Tropical Medicine inherently different responses to pathogensor apoptotic
cells, e.g., due to differential expression of adhesionKeppel Street
London WC1E 7HT (Belz et al., 2002; Engering et al., 2002; Iyoda et al., 2002;
Schulz et al., 2002) or Toll-like receptors (Kadowaki et al.,United Kingdom
2001; Krug et al., 2001), each also exhibits considerable
functional plasticity (Manickasingham et al., 2003). Re-
cently, attention has focused on DC with regulatorySummary
properties. Wakkach et al. (2003) have described a natu-
ral subset of CD11cloCD45RBhi DC with the capacity toCD11chi dendritic cells (DC) play an essential role dur-
secrete IL-10 after lipopolysaccharide (LPS) (and to aing the initiation of cell-mediated immunity. Recently,
lesser extent CpG) stimulation and skew T cell develop-CD11cloCD45RBhi DC with regulatory properties have
ment toward a regulatory (Tr1) phenotype (Groux et al.,been described. However, the origins of regulatory DC
1997). IL-10 promotes the development of CD11cloare poorly understood. Here, we show that spleen-
CD45RBhi DC, in as much as these cells develop morederived stromal cells promote selective development
readily in bone marrow cultures supplemented withof CD11cloCD45RB IL-10-producing regulatory DC
IL-10 and CD11cloCD45RBhi DC are found at greater fre-from lineage-negative c-kit progenitor cells. These
quency in the spleen of IL-10 transgenic mice (WakkachDC have the capacity to suppress T cell responses
et al., 2003). Although CD11cloCD45RBhi DC are found inand induce IL-10-producing regulatory T cells in vitro
low numbers in the resting spleen, it is unknownwhetherand to induce antigen-specific tolerance in vivo. Fur-
these develop locally or are recruited following differen-thermore, stromal cells frommice infected with Leish-
tiation in the bone marrow. Although DC with a regula-mania donovanimore effectively supported differenti-
tory phenotype have been implicated in tolerance induc-ation of these highly potent regulatory DC. The ability
tion (Steinman et al., 2003), their possible contributionof tissue stromal cells to direct the development of
to the development of chronic infection has also yet toDC with a regulatory phenotype thus provides a new
be examined.mechanism for local immune regulation.
In this study,wedemonstrate that spleen stromal cells
are capable of directly supporting the development ofIntroduction
CD11cloCD45RB IL-10-producing DC from lineage-
negative c-kitprogenitor cells, in the absence of exoge-Dendritic cells (DC) are a heterogeneous family of cells
nous cytokines. Moreover, stromal cells from L. dono-with pivotal roles in the initiation and subsequent devel-
vani-infected mice are more efficient at supporting theopment of immune responses (Banchereau et al., 2000;
development of these CD11cloCD45RB DC. In vitro,Banchereau and Steinman, 1998). Various subsets of
DC that differentiate on stromal cells suppress mixedCD11chi DC have been characterized and are most
leukocyte reaction responses and induce primary allore-readily identified in the murine spleen by expression
active CD4 T cells to differentiate into IL-10-producingof CD11b, CD4, and CD8 (Vremec et al., 2000). The
Tr1 cells. In vivo, adoptive transfer of these DC leadslineage relationships of these subsets are complex, and
to antigen-specific tolerance. Together, these data sup-a full picture has yet to emerge (Ardavin, 2003). Never-
port a model whereby, under steady-state conditions,theless, it is apparent that all three major CD11chi sub-
CD11cloCD45RB DC are generated in situ at low fre-sets can bederived in vitro frombonemarrowprogenitor
quency from locally found progenitor cells. However,cells and that the relative frequency of each is largely
following parasitic infection, progenitor cells recruiteddependent upon the prevailing cytokine environment.
from the bone marrow and/or undergoing more rapidFor example, whereas GM-CSF favors development of
local self-renewal aremore efficiently instructed by stro-CD11chiCD11b DC (Inaba et al., 1992), CD11chiCD8
mal cells to develop into these highly potent regulatoryDC preferentially arise when Flt-3L is added to culture
DC. The ability to program DC development in this way(Brasel et al., 2000).
endows stromal cells with striking and previously unrec-Different subsets of CD11chi DC are recognized to
ognized immunoregulatory potential.
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Japan. 2003; Hasthorpe et al., 1992; Morris et al., 1991). Follow-
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Figure 1. Stromal Cells Direct Differentiation of CD11cloCD45RB DC
(A) Characterization of splenic stromal cell layers prepared from naive C57BL/6 mice. Splenic stromal cells were identified by direct visualization
under Nomarsky imaging (left panels) or following staining with ER-TR7 or CD68 (green) and phalloidin (false-colored blue).
(B) Stromal cells cocultured with BMLin progenitor cells were examined by Nomarsky imaging on days 1, 2, 4, and 6.
(C) Outgrowing cells were examined for CD11c (red) expression by using immunofluorescence confocal microscopy. The bars in (A)–(C)
indicate 10 m.
(D) CD11b and CD11c expression on nonadherent cells generated in stromal cell-progenitor cell cocultures (stroma DC) compared to GM-
CSF-derived DC. Quadrant gates were set on appropriate isotype controls.
(E) Expression of CD45RB on CD11c DC developing on stomal cells and GM-CSF-derived DC.
(F) Phenotype of DC developing in cultures of CD45.1 progenitor cells and CD45.2 stromal cells. GM-CSF-derived DC from B6 (CD45.2)
mice were used as a staining control.
ing collagenase digestion and adherence, a population macrophages (CD169). In the spleen of normal mice,
approximately 5% of myeloid progenitor cells are in ac-of spleen-derived stromal cells could be isolated. These
stromal cells (Figure 1A) were heterogeneous and com- tive cell cycle (Cotterell et al., 2000a), indicating that a
low level of myelopoietic activity occurs during theprised principally fibroblasts expressing the ER-TR7 an-
tigen (51%  5%) and resident CD68 macrophages steady state. To determine whether spleen stromal cells
had the capacity to support the local differentiation of(44%  4%). Less than 5% of cells in these cultures
stained for markers of endothelial cells (CD31), marginal DC, stromal cells were isolated from B6 (CD45.2) mice
and were cocultured with progenitor cells (BMLinzonemacrophages (ER-TR9), andmarginalmetallophilic
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cells;95% lineage marker and80% c-kit; data not contrast, CD11cloCD45RB DC derived on stromal cells
were completely unable to stimulate an MLR, even aftershown) isolated from congenic B6.CD45.1 mice. Cocul-
tures were established in the absence of exogenous culture with TNF (Figure 3A). To determine if these cells
had regulatory capacity, we tested their capacity to in-growth factors, to avoid biasingDCdevelopment.Within
24–48 hr, BMLin cells associated strongly with stromal hibit an MLR stimulated by CD11chi DC. As few as 103
CD11cloCD45RB DC could suppress the MLR inducedcells, and over the following 4 days, there was clear
evidence of cell clustering and proliferation (Figure 1B). by 3  103 CD11chi DC by almost 50%, and when ad-
mixed at a 1:1 ratio, the degree of suppression increasedBy day 6 of culture, cells with a DC phenotype and
staining for CD11c (Figure 1C) had emerged in these to approximately 75% (Figure 3B). In addition, treatment
with TNF did not abrogate the suppressive function ofcultures. Most of these DC no longer associated with
stromal cells and could be harvested as a nonadherent these DC (74%  3% versus 72%  7% suppression
for control and TNF-treatedDCat a 1:1 ratiowithCD11chipopulation. DC developing on stromal cells expressed
only low levels of CD11c compared to BMLin cells that DC). Given that the regulatory function of bone marrow-
derived CD11cloCD45RBhi DC has been attributed to IL-had been differentiated into DC for the same period of
time by using GM-CSF, whereas both populations were 10, we determined whether the CD11cloCD45RB DC
derived on stromal cells also produced IL-10. CD11clo-95% CD11b (Figure 1D). In contrast to GM-CSF-
derived DC, however, DC that developed on stromal CD45RB DC were isolated from culture, and the spon-
taneous accumulation of IL-10 mRNA was determinedcells were uniformly CD45RB (Figure 1E). Staining for
CD45.1 and CD45.2 confirmed that all DC in these cul- by real-time RT-PCR. IL-10 mRNA accumulation was
10-fold greater in CD11cloCD45RB DC compared totures derived from progenitor cells and that they did not
represent an expansion of contaminating DC copurified that seen in CD11chi DC (0.12 versus 0.01 molecules of
IL-10 mRNA/1000 HPRT mRNA molecules, respec-within the stromal cells (Figure 1F). From an input of
50  103 progenitor cells, approximately 2.5  0.5  tively). To determine whether IL-10 contributed to the
regulatory activity of these DC, we used an anti-IL-10R103 CD11cloCD45RB DC were recovered, compared to
55  10  103 CD11chi DC from the same number of mAb (Figure 3C). Blockade of IL-10 receptor binding
reduced the regulatory capacity of CD11cloCD45RBDCBMLin cells cultured with GM-CSF. As progenitor cells
appeared to bind avidly to stromal cells during culture by approximately 60% (p  0.02). In contrast, the addi-
tion of anti-IL-10R mAb to MLR stimulated by GM-CSF-and a variety of adhesion molecules have been impli-
cated in stromal cell-progenitor cell interactions (Verfail- derived DC had no effect (59,090  10,950 versus
56,096  3,196 versus 50,211  6,395 cpm for MLR inlie, 1998), we assessed the importance of adherence for
the development of CD11cloCD45RBDC in this system. the presence of no mAb, isotype control mAb, and anti-
IL-10R mAb, respectively). To determine whether TGF	,When stromal cells and progenitor cells were separated
across a transwell membrane, the number of DC recov- another anti-inflammatory cytokine implicated in regula-
tory function (Letterio and Roberts, 1998) was involvedered was significantly reduced, from 2.5  0.5  103 to
1.0  0.4  103 recoverable DC per culture (p  0.04). in inhibition of these MLR responses, we used a neu-
tralizing anti-TGF	 antibody. However, no reversal ofTrypsin treatment of stromal cells also gave similar re-
sults, suggesting that trypsin-sensitive adhesion mole- the regulatory function was observed (Figure 3D). Thus,
CD11cloCD45RB DC generated on stromal cells fromcules were involved in this contact-dependent develop-
ment of CD11cloCD45RB DC (data not shown). naive mice have a partially IL-10-dependent, but TGF	-
independent, regulatory function.Morphologically, DC that developed on stromal cells
were similar to BMLin cells expanded for 6 days with
GM-CSF (Figure 2A). Following 2 days of culture in TNF, DC Development on Stromal Cells
however, CD11cloCD45RB DC assumed a more mature from Leishmania-Infected Mice
phenotype. TNF stimulated the appearance of multiple The identification of regulatory DC suggests that such
dendritic processes (Figure 2A), a 5- to 6-fold increase cells might play a role in the development of chronic
in surface CD11c expression (Figure 2B), and the redis- or persistent infections. Murine visceral leishmaniasis
tributionofMHCclass IImolecules fromapredominantly causes chronic infection associated with marked sple-
intracellular location to the plasma membrane (Figure nomegaly, immunosuppression, and the development
2C). TNF treatment also induced increased expression of CD4 T cells producing regulatory cytokines (Gomes
of CD40 (MFI of 64  5 versus 145  5 for untreated et al., 2000; Wilson et al., 2002). As previously reported
and TNF-treated DC, respectively; p  0.05), but not by us in BALB/c mice (Ato et al., 2002), chronic L. dono-
CD86 (MFI of 10  1 versus 20  5; not significant). vani infection of B6 mice is accompanied by alterations
Collectively, these data indicate that DCderived on stro- in the number and distribution of DC in the spleen, and
mal cells have phenotypic characteristics in common DC in these mice also acquire the capacity to inhibit
with both bone marrow-derived CD11cloCD45RBhi DC protective immunity on adoptive transfer into infected
(Wakkach et al., 2003) and immature DC (Cella et al., mice (A.M. et al., in preparation). During L. donovani
1997; Pierre et al., 1997). infection, bonemarrow-derivedmyeloid progenitor cells
are also rapidly recruited into the blood and are found
in increased numbers in the spleen, where 50% areDC Derived on Stromal Cells Have
Regulatory Function in the active cell cycle (Cotterell et al., 2000a). Our find-
ings that stromal cells can directly support the differenti-CD11chi DC derived from BMLin cells by using GM-
CSF are efficient stimulators of naive T cells in MLR, ation of CD11cloCD45RB IL-10-producing DC frompro-
genitor cells prompted us to evaluate whether stromalparticularly after stimulation with TNF (Figure 3A). In
Immunity
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Figure 2. Maturation of CD11cloCD45RB DC
(A) Morphology of CD11cloCD45RB DC derived on stromal cells (stroma DC) compared to GM-CSF-derived DC in the absence (top panels)
or presence (bottom panels) of TNF.
(B) Expression of CD11c (mean fluorescence intensity; MFI) on stroma DC in the absence (open bar) or presence (black bar) of TNF. Data
represent mean  SEM.
(C) Localization of MHC-II (green) and CD11c (red) on stroma DC in the absence (top panel) or presence (bottom panel) of TNF.
cells from infected mice might similarly be efficient at development of an environment that supports chronic
infection.directing progenitor cells along the CD11cloCD45RB
DC developmental pathway and hence contribute to the Although stromal cells have generally been disre-
garded in studies of the immune response to parasitic
infection, we and others have previously documented
that stromal fibroblasts andmacrophages are targets for
infection by Leishmania (Bogdan et al., 2000; Cotterell
et al., 2000b). By immunohistochemistry, intracellular
amastigotes are readily identified in the spleen of mice
with chronic L. donovani infection, andmanycolocalized
with ER-TR7 fibroblasts and CD68macrophages (Fig-
ure 4A). In isolated stromal cell preparations, intracellu-
lar amastigoteswere also readily observed in bothpopu-
lations (Figure 4B). Although CD68 macrophages from
infected mice had a more flattened and discoid appear-
ance than those from naive mice, and loss of T zone
gp38 stromal cells occurs during infection (Ato et al.,
2002), in other respects there was little apparent differ-
ence in the cellular composition of the stromal cell prep-
arations isolated from naive and infected mice (51% 
4% ER-TR7, 45%  5% CD68).
We first compared the ability of stromal cells from
naive and infected mice to support DC development.
Stromal cells from infected mice clearly supported the
development of CD11clo DC and in 4-fold greater num-
bers than an equivalent number of stromal cells from
naivemice (Figure 4C). Similarly to the stroma fromnaive
mice, adherence was critical for the optimal develop-
ment of CD11clo DC on stromal cells from infected mice
Figure 3. Regulatory Function of CD11cloCD45RB DC (Figure 4C). IL-10 has been suggested as a growth/
(A) CD4 T cells from BALB/c mice were stimulated with normal differentiation factor for CD11cloCD45RBhi DC derived
(open symbols) or TNF-treated (closed symbols) GM-CSF-derived
in conventional bone marrow cultures (Wakkach et al.,DC (squares) or CD11cloCD45RBDC (circles) derived fromB6mice.
2003). As differential IL-10 production could account forThymidine incorporation was determined on day 4. Responses of
the differing capacity of stromal cells from infected andnormal and TNF-treated CD11cloCD45RB are overlapping.
(B) Inhibition of MLR stimulated by 3  103 GM-CSF-derived DC by naive mice to support the development of CD11clo-
indicated numbers of CD11cloCD45RB DC (stroma DC). CD45RB DC, we measured IL-10 mRNA accumulation
(C) Reversal of CD11cloCD45RB DC function by IL-10R antibody in these two stromal populations. No differences in IL-
(10R), but not by isotype (Iso) control.
10 mRNA levels were observed, however (data not(D) TGF	 antibody (TGF) does not reverse the function of CD11clo-
shown). To determine whether stromal cells from naiveCD45RB DC.
Data represent mean  SEM. and infected mice differed in their capacity to support
DC Development on Stromal Cells
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Figure 4. Stromal Cells from L. donovani-
Infected Mice Support Enhanced Differentia-
tion of CD11cloCD45RB DC
(A) In situ colocalization of L. donovani amas-
tigotes (red; L.donovani antibody) with ER-
TR7- and CD68-expressing cells (green). 6
m cryosections and confocal microscopy.
(B) Isolated stromal cells from infected mice
stainedwith ER-TR7 (green), phalloidin (false-
colored blue), and L. donovani antibody (red)
(top panel) or CD68 (green), phalloidin (blue),
and propidium iodide to visualize both host
cell and parasite nuclei (red) (bottom panel).
(C) Recovery of CD11cloCD45RB DC from
cultures containing stromal cells from naive
or infected mice in direct contact with progeni-
tor cells (open bars) or separatedby a transwell
(black bars). Data represent mean  SEM.
(D) Progenitor cell survival in cultures con-
taining stromal cells from naive mice (open
bars) and infected mice (black bars). Data
represent mean  SEM.
early progenitor survival, we counted the number of sur- developed on stromal cells from naive mice or with GM-
CSF-derived CD11chi DC.viving progenitor cells during the initial 48 hr of culture
and prior to obvious progenitor cell division. BMLin We next determined whether the CD11cloCD45RB
DC developing on stromal cells from naive and infectedcells cultured in the presence of stromal cells derived
from naive mice were 50% viable at 24 hr, but only 20% mice were similar in their regulatory properties. CD11clo-
CD45RB DC developing on stromal cells from infectedremained viable at 48 hr. In contrast, stromal cells from
infected mice supported extended survival of BMLin mice were also unable to stimulate an MLR, even after
maturation with TNF (Figure 6A). However, in compari-cells during this early period of culture (Figure 4D). This
differential survival of progenitor cells may partly ac- son to CD11cloCD45RB DC generated on stromal cells
fromnaivemice, theseDChadmarkedly enhanced regu-count for the increased output of DC in cultures con-
taining stromal cells from infected mice. latory potential, capable of inhibiting theMLRstimulated
by CD11chi DC by greater than 95% (Figure 6B). TheSimilar to DC that developed on stromal cells from
naive mice, CD11clo DC that develop on stromal cells regulatory capacity of CD11cloCD45RB DC that had
developed on stromal cells from infected mice couldfrom infectedmicewere also uniformlyCD45RB (Figure
5A), lacked surface MHC class II (data not shown), and also be partially overcomewith anti-IL-10RmAb, though
to a lesser extent than seen for CD11cloCD45RB DCcould be matured in the presence of TNF to increase
expression of CD11c (Figure 5B) and redistribute intra- that had developed on stromal cells from naive mice,
and, again, not by anti-TGF	 mAb (Figure 6C). CD11clo-cellular MHC class II to the cell surface (Figure 5C).
However, CD11c expression after TNF treatment was CD45RB DC developing on stromal cells from infected
mice also accumulated very high levels of IL-10 mRNA,upregulated to a lesser extent (only approximately
3-fold) compared to that seen with TNF-treated DC that approximately 10-fold greater than levels observed in
CD11cloCD45RB DC that developed on stromal cellsdeveloped on stroma from naive mice (data not shown
and Figure 2B), whereas CD40 and CD86 expression from naive mice, and over 400-fold greater than levels
in CD11chi DC (Figure 6D).changed similarly to that seen with DC generated on
naive stromal cells (CD40 MFI of 56  7 versus 161  Together, these data indicate that stromal cells in the
spleen of mice with chronic L. donovani infection have9 and CD86 MFI of 23  3 versus 30  2, respectively,
for control and TNF-treated DC that developed on heightened capacity to generate regulatory CD11clo-
CD45RBDC fromprogenitor cells compared to stromalstroma from infected mice). Although these CD11clo-
CD45RB DC also responded to TNF with dendrite for- cells from naive mice.
We next performed experiments to determinewhethermation (Figure 5D), this response was rather muted
compared to that seen with CD11cloCD45RB DC that these CD11cloCD45RB DC were capable of inducing
Immunity
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Figure 5. Maturation of CD11cloCD45RBDC
Derived on Stroma from Infected Mice
(A) CD45RB expression (solid line) on CD11clo-
MHC-IIlo/ DC derived on stromal cells from
infected mice. The thin line represents iso-
type control.
(B) Expression of CD11c and CD11b on
CD11cloCD45RBDC cultured in the absence
(left panel) or presence (right panel) of TNF.
(C) Distribution of MHC-II (green) and CD11c
(red) in CD11cloCD45RB DC cultured in the
absence (top panels) or presence (bottom
panels) of TNF. The scale bar equals 10 m.
(D) Morphology of CD11cloCD45RB DC fol-
lowing exposure to TNF (Giemsa stained).
the differentiation of CD4 T cells with a regulatory phe- incomplete Freund’s adjuvant [IFA]) after an additional
7 days. Serum IgG1 and IgG2a responses to OVA andnotype. First, we examined the cytokine responses of
CD4 T cells that had differentiated duringMLR induced KLH were measured at each time point. Following pri-
mary immunization, control, untreated mice made abyeitherCD11cloCD45RBDCorbyCD11chi DC (Figures
6E and 6F). CD4 T cells were isolated from these MLR readily detectable IgG1 response to OVA, which was
not significantly improved by prior transfer of antigen-and were restimulated with normal, irradiated spleen
cells as a source of antigen presenting cells (APC), and pulsed, GM-CSF-derived CD11chi DC. In contrast, prior
transfer of OVA-pulsed DC derived on stromal cells fromsupernatants were assayed for IL-10 and IFN
 at 48 hr.
CD11cloCD45RB DC induced CD4 T cells that se- naive or infectedmice significantly suppressed the IgG1
response to OVA (p  0.001 and p  0.0001, respec-creted IL-10 (Figure 6E) and not IFN
 (Figure 6F). In
contrast, CD11chi DC primed CD4 T cells to secrete tively), but not the response toKLH (Figure 7A). Similarly,
even after secondary immunization, the response toIFN
, but not IL-10. To test if CD4 T cells primed by
CD11cloCD45RBDChad also acquired regulatory func- OVA (Figure 7B), but not KLH (Figure 7C), was signifi-
cantly inhibited in mice receiving DC derived on stromaltion, we added them to new primary MLR cultures con-
taining naive CD4 T cells and irradiated spleen APC cells. In these experiments, IgG2a responses in all
groups of mice were weak, but we found no evidence(Figures 6G–6I). CD4 T cells primed on CD11clo-
CD45RBDCderived on stromal cells fromnaive (Figure of skewing toward an IgG2a response in mice receiving
DC derived on stromal cells (data not shown).6G) and infected (Figure 6H) mice potently inhibited this
primary MLR, whereas CD4 T cells primed on CD11chi We next addressed the question of whether tolerance
in thismodelwasmediated byCD4T cells. CD4T cellsDC, as expected, contributed to it (Figure 6I). Thus,
in vitro, CD11cloCD45RB DC induce IL-10-producing were isolated from naive mice or mice that had received
OVA-pulsed CD11cloCD45RB DC 7 days previously.Tr1-type CD4T cells.
These CD4 T cells were adoptively transferred into
naive mice, and 1 day later, recipients were immunizedDC Derived on Stromal Cells Induce
Tolerance In Vivo and then boostedwithOVA-CFA or KLH-CFA (as above).
CD4 T cells isolated from mice that had received OVA-To determine whether these DC had functional activity
in vivo, DCwere pulsed overnight in vitro with ovalbumin pulsedCD11cloCD45RBDC inhibitedOVA-specific, but
not KLH-specific, IgG1 (Figures 7D and 7E) and IgG2a(OVA) (in the presence of TNF for the final 8 hr) and then
transferred (3  105) into naive recipients. Mice were (Figures 7F and 7G) responses in these recipients, con-
firming that CD11cloCD45RB DC do indeed induceimmunized 7 days later with OVA-complete Freund’s
adjuvant (CFA) or keyhole limpet hemocyanin (KLH)-CFA the differentiation of antigen-specific regulatory CD4
T cells in vivo.and were subsequently boosted (by using antigen in
DC Development on Stromal Cells
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Figure 6. Regulatory Function of CD11clo-
CD45RB DC Derived on Stroma from In-
fected Mice
(A) CD4 T cells fromBALB/cmice were stim-
ulated with normal (open) or TNF-treated
(closed) GM-CSF-derived DC from B6 mice
(squares) or CD11cloCD45RB DC derived on
stromal cells from infected B6 mice (circles).
Thymidine incorporation was determined on
day 4. Responses of normal and TNF-treated
CD11cloCD45RB are overlapping. Data rep-
resent mean  SEM.
(B) Inhibition of MLR stimulated by 104 GM-
CSF-derived DC by indicated numbers of
CD11cloCD45RBDC derived on stroma from
naivemice (black bars) or infectedmice (open
bars). Data represent mean  SEM.
(C) Effect of IL-10R antibody (10R) and TGF	
antibody (TGF) on the regulatory function of
CD11cloCD45RBDC derived on stroma from
infected mice. Data represent mean  SEM.
(D) IL-10 mRNA accumulation in GM-CSF-
derived CD11chi DC (open bars) and CD11clo-
CD45RB DC derived on stromal cells from
naive mice (black bar) or infected mice
(hatched bar).
(E and F) Production of (E) IL-10 and (F) IFN

by alloreactive BALB/c CD4 T cells recov-
ered from primary culture with CD11clo-
CD45RB DC derived on stromal cells from
naive (black bars) or infected (hatched bars)
B6 mice or with B6 GM-CSF-derived DC
(open bars). Control cultures were stimulated
with syngeneic BALB/c DC. n.d. signifies be-
low detection limits of 100 pg/ml (IL-10) and
50 pg/ml (IFN
). Data represent mean SEM.
(G–I) Effect of graded numbers of CD4
T cells primed by using CD11cloCD45RB DC
derived on stromal cells from (G) naive or (H)
infected mice or (I) GM-CSF-derived DC on the
primary MLR of 105 naive CD4 T cells. The
response in the absence of B6 APC was less
than 100 cpm. Data represent mean  SEM.
Discussion regulatory capacity, under the guidance of resident stro-
mal cells. In this context, therefore, stromal cells may
indirectly facilitate the generation of tolerogenic signalsThe finding that splenic stromal cells support the differ-
entiation of DCwith potent capacity to induce regulatory to self-antigens normally removed from the circulation
by the spleen (Higgins et al., 2002). The stroma used inCD4 T cells has important implications for our under-
standing of local immune regulation. First, our data dem- this study represent a heterogeneous population,mainly
comprising fibroblasts and macrophages. Preliminaryonstrate that stromal cells in the spleen can, under
steady-state conditions, impart a selective program of in vitro studies indicate that stromal fibroblast and stro-
mal macrophage cell lines, but not conventional macro-DC differentiation on lineage-negative progenitor cells.
Progenitor cells with capacity to differentiate down the phage cell lines, have the capacity to support the devel-
opment of the DC described here (unpublished data),myeloid lineage are normally present at low frequency
in the resting murine spleen, and suicide depletion ex- providing a model in which to further elucidate stromal
cell-progenitor cell interactions. Such characterizationperiments indicate a modest turnover rate (Cotterell et
al., 2000a). Our new data indicate that some of these of the molecular events leading to the development of
CD11cloCD45RB DC may provide novel means to ma-progenitor cells can differentiate in situ into DC with
Immunity
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Figure 7. CD11cloCD45RB DC Derived on Stromal Cells Induce Antigen-Specific Tolerance In Vivo
(A) OVA-pulsed, GM-CSF-derived CD11chi DC or DC derived on stromal cells from naive or infected mice were transferred into naive B6 mice
(n  6), which were immunized 7 days later with OVA-CFA or KLH-CFA. Serum IgG1 responses (at 1:100) to OVA (open bars) and KLH (black
bars) were measured 7 days after immunization. *p  0.001, **p  0.0001 versus no transfer control.
(B and C) Mice received no cells (open squares), OVA-pulsed, GM-CSF-derived DC (closed squares), or OVA-pulsed, DC derived on stromal
cells from naive (closed triangle) or infected (closed diamond) mice, and were then immunized with OVA-CFA or KLH-CFA, followed 7 days
later by boosting with antigen in IFA. Serum IgG1 responses to OVA (B) and KLH (C) were measured 7 days after boosting. OVA-specific IgG1
responses were significantly lower in mice receiving DC derived on stromal cells compared to control mice at all dilutions tested. No significant
differences in anti-KLH response were seen.
(D–G) B6 mice received 4  106 CD4 T cells from naive mice (open symbols) or mice that had been adoptively transferred 7 days earlier with
OVA-pulsed CD11cloCD45RB DC derived on stromal cells from infected mice (closed symbols). One day after T cell transfer, recipient mice
were immunized and boosted with OVA-CFA or KLH-CFA. Serum (D and E) IgG1 and (F and G) IgG2a responses to (D and F) OVA and (E and
G) KLH were determined. †, p  0.05; ††, p  0.01; *, p  0.001, **, p  0.0001.
In all panels, data represent mean  SEM.
nipulate DC with regulatory properties in vivo. The data ration under the influence of TNF does not, however,
alter the regulatory potential of these CD11clo-presented in this manuscript indicate that these events
include both cellular adhesion and the production of CD45RB DC. Furthermore, CD11cloCD45RB DC de-
rived on stromal cells constitutively produced IL-10 andsoluble mediators.
The CD11cloCD45RB DC derived on spleen stromal could inhibit MLR, whereas IL-10 production by bone
marrow-derived CD11cloCD45RBhi DC required expo-cells that we describe here have characteristics in com-
mon with the regulatory CD11cloCD45RBhi DC described sure to LPS or GpG (Wakkach et al., 2003). Both the DC
described here and those described by Wakkach et al.by Wakkach et al. (2003), for example, in their immature
phenotype and expression of CD45RB, but are unique also have the capacity to induce IL-10-producing Tr1-
type regulatory CD4 T cells in vitro and to induce anti-in some other respects. The immature phenotype does
not appear stable, as described for bone marrow- gen-specific tolerance in vivo. The precise relationship
between these two highly potent regulatory DC popula-derivedCD11cloCD45RBhi DC (Wakkach et al., 2003), and
both morphology and subcellular distribution of MHC tions awaits clarification.
The second major outcome from this study is theclass II can bemodified by exposure to TNF. Suchmatu-
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hamsters. Amastigotes were isolated from infected spleens, as pre-demonstration that stromal cells frommice infectedwith
viously described (Stager et al., 2000), and mice were infected withL. donovani are more potent in their capacity to support
2  107 L. donovani amastigotes intravenously in 200 l RPMI 1640the development of CD11cloCD45RB DC. Furthermore,
(Invitrogen). Mice were sacrificed 28–35 days postinjection by CO2CD11cloCD45RB DC derived on stromal cells from in- suffocation. Spleens were collected and used for DC or stromal
fectedmicemakemore IL-10 and aremore potent inhibi- preparations or were embedded in O.C.T. compound (Raymond
Lamb) and snap frozen in liquid nitrogen. All animal care and experi-tors of MLR than those derived by using stromal cells
mental procedures were approved by the LSHTM Animal Proce-from naive mice. The functional distinction between DC
dures and Ethics Committee and were conducted in accord withderived on stromal cells from naive and infected mice
UK Home Office requirementsis less evident when the development of Tr1 cells is
directly examined and from in vivo experiments per-
Splenic Stromal Cell Preparations
formed to date, and we cannot exclude at this stage Stroma from naive or infected B6 mice were obtained by perfusing
that their increased potency in inhibiting a primary MLR spleens with RPMI 1640 followed by 0.5 mg/ml collagenase (Wor-
is due to additional suppressive qualities. Previously, we thington Biochemical), then spleens were cut in small pieces with
a scalpel and incubated in 0.5 mg/ml collagenase for 45 min at roomhave shown that myeloid progenitor cells are mobilized
temperature on a rotating wheel. Digested spleens were washedfrom the bone marrow during the course of L. donovani
twice with RPMI 1640 by centrifugations at 20  g for 15 min.infection, with sustained numbers in the peripheral cir-
Pelleted cells were resuspended in complete Dulbecco’s modified
culation from day 7 of infection onward (Cotterell et al., Eagle’s medium (DMEM, 50 M 2-mercaptoethanol, 100 U/ml peni-
2000a). In the spleen, the number of progenitor cells cillin, 100 g/ml streptomycin, 10 mM HEPES, nonessential amino-
continues to rise throughout 56 days of infection, due acids, all from Invitrogen; 1mM sodiumpyruvate, 2mML-glutamine,
both from Sigma-Aldrich) supplemented with 10% fetal calf serumto a combination of recruitment and self-renewal (Cot-
(FCS, Sigma-Aldrich), seeded (107) in 90 mm Petri dishes (Nunc),terell et al., 2000a). Hence, the combination of increased
and incubated for 4 hr at 37C to allow cell adherence. Petri dishesprogenitor cell number and stromal cell activity makes
were washed three times with RPMI 1640 to remove nonadherent
the spleen a highly potent site for the development of cells. The adherent cells were removed by incubation in enzyme-
regulatory DC during visceral leishmaniasis. The exag- free cell dissociation buffer (Sigma-Aldrich) at 37C for 30 min and
gerated development of DC with regulatory potential in by using a cell lifter (Corning). Collected cells were washed twice
in RPMI 1640 by centrifugations at 60  g for 15 min. Cells werethe spleen of mice with chronic visceral leishmaniasis
resuspended in complete DMEM supplemented with 10% FCS, andmight provide one explanation for the observed increase
1  104, 5  104, or 1  105 cells were seeded in 96- (TPP), 24-in regulatory T cells that hasbeennotedas acharacteris-
(TPP) or 12-well (Corning) plates, respectively, or 5  104 cells were
tic of this disease (Gomes et al., 2000;Wilson et al., 2002) seeded onto glass coverslips in 24-well plates. Cells were incubated
(S. Stager, personal communication) and the chronic overnight in humidified, 5%CO2 incubators at 37Cand thenwashed
nature of this infection. twice with RPMI 1640 to remove any remaining transiently and non-
adherent cells, leaving a monolayer of splenic stromal cells.In conclusion, we have demonstrated that stromal
cells can play an active role in directing the differentia-
Purification and Culture of Progenitor Cellstion of DC with regulatory function. In addition to the
Bone marrow cells were obtained by aspirating femurs and tibiae.impact this may have on the outcome of parasitic dis-
BMLin cells were purified by using a cell lineage depletion kit
ease, the ability of stromal cells to program DC develop- (Milteneiy Biotech) following the manufacturer’s protocol. Briefly,
ment may also represent a more general requirement bone marrow cells were labeled with biotinylated antibodies to
to terminate immune responses and restore tissuehomeo- CD11b, CD5, CD45R, Ly-6G, 7-4, and TER-119 at 4C for 10 min in
PBS containing 0.5% BSA and 5 mM EDTA (Sigma-Aldrich). Thestasis following inflammation. Increased myelopoietic ac-
cells were then incubated with anti-biotin-conjugated immunomag-tivity is observed in a number of other infectious and
netic beads at 4C for 15 min in PBS containing 0.5% BSA andnoninfectious inflammatory diseases (Alvarez-Silva et
5 mM EDTA. After washing, lineage-positive cells were removed on
al., 1993; Jordan et al., 2003; Young and Cheers, 1986; a MidiMACS separation column, and Lin cells were recovered from
Zhan and Cheers, 2000; Zhan et al., 1998), often in con- the flow-through. 5  104 or 2  105 BMLin cells were cultured
cert with local tissue remodeling and changes to local together with splenic stromal cells in 96- or 24-well plates, respec-
tively, or BMLin cells were cultured in Transwell inserts (0.4 mstromal cell populations (Ato et al., 2002; Engwerda et
pore-size; Corning) with stromal cells in the lower chamber. Alterna-al., 2002; Smelt et al., 1997). Similarly, stromal cell popu-
tively, BMLin cells were cultured in 10% culture supernatant fromlations have been reported to become significantly al-
a myeloma cell line transfected with murine GM-CSF cDNA. All
tered in function in the vicinity of a variety of tumors cultures containing BMLin cells were performed with complete
(Elenbaas and Weinberg, 2001; Kunz-Schughart and DMEM supplemented with 5% FCS in humidified, 5% CO2 incuba-
Knuechel, 2002; Silzle et al., 2003). Our data open the tors at 37C. As required, TNF (10 ng/ml) was added for the final 48
hr of culture.possibility that stromal cell regulation of local DC differ-
entiation may occur in many or all of these situations,
Flow Cytometrycontributing significantly to disease outcome. Whether
For flow cytometry, cells were incubated with 10 g/ml 2.4G2 anti-the program of DC differentiation imparted by stromal
Fc receptormAb (ATCC), followedby stainingwith direct conjugatedcells is always the same will be important to discover.
monoclonal antibodies. Cells were stained with fluorescein isothio-
cyanate (FITC)-conjugated anti-CD11b (clone M1/70), anti-CD45.2
(Ly5.2, clone 104), anti-MHC-II (clone 2G9), or anti-CD8 (clone 53-Experimental Procedures
6.7) antibodies; phycoerythrin (PE)-conjugated anti-CD11b (clone
M1/70), anti GR-1 (RB6-8C5), anti-CD45R/B220 (clone RA3-6B2),Mice and Infection
C57BL/6 (B6) and BALB/c mice were purchased from Charles River, anti-CD45RB (clone 16A), biotinylated anti-CD45.1 (Ly5.1, clone
A20), or anti-MHC-II (clone 2G9) antibodies; and APC-conjugatedand B6.CD45.1 mice were bred at LSHTM. Mice were used at 6–10
weeks of age and were housed under conventional conditions with CD11c (clone HL3) antibody (all from BD Pharmingen). Labeling with
biotinylated antibodies was visualized with PerCP-streptavidin (BDfood and water ad libitum. Parasites of the Ethiopian strain of Leish-
mania donovani (LV9) were maintained by serial passage in Syrian Pharmingen). Minimal background staining was observed by using
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control FITC-conjugated, PE-conjugated, biotinylated mouse and used for specific amplification of IL-10 were AGGGTTACTTGGGTT
GCCAA (sense) and CACAGGGGAAAAATCGATGA (antisense), andrat IgG2a and IgG2b antibodies, and APC-conjugated hamster IgG
antibody (all from BD Pharmingen). All staining was performed on for amplification of the housekeeping gene HPRT they were GTT
GGATACAGGCCAGACTTTGTTG (sense) and GATTCAACCTTGCGice in Hank’s balanced salt solution (HBSS, GIBCO) containing 2%
FCS, 5mM EDTA, and 0.01% sodium azide for 20 min. Flow cytome- CTCATCTTAGGC (antisense). Samples were amplified under the
following conditions: 15 s denaturation at 95C, 30 s annealing attry analysis was performed with an FACSCalibur (BD Biosciences)
on 10,000 or 200,000 cells and was analyzed by using CellQuest 62C, and 30 s extension at 72C (40 cycles for IL-10 and HPRT).
The number of IL-10 and HPRT cDNA in each sample was calculatedsoftware (BD Biosciences).
by real-time reverse transcription PCR by using a QuantiTect SYBR
green master mix (Qiagen) and a LightCycler (Applied Biosystems)Immunofluorescence and Confocal Analysis
according to the manufacturers’ instructions. Standard curves wereFor immunofluorescence labeling, 6mcryostat sectionswere fixed
constructed with known amounts of IL-10 and HPRT cDNA, and thein ice-cold acetone for 10 min, and cells on coverslips were fixed
number of IL-10molecules per 1000HPRTmolecules in each samplein 4% paraformaldehyde for 30 min at room temperature (RT). After
was calculated.fixing, samples were quenched with 50 mM NH4Cl in PBS for 30 min
at RT, and then blocked and permeablized by incubation with 1.5%
Adoptive Transfer of Dendritic Cellsv/v normal goat serum in 0.1% v/v saponin in PBS for 45 min at RT.
Dendritic cells generated from B6CD45.1 BMLin progenitors ex-Samples were incubated with purified antibodies diluted in 1.5%
panded in GM-CSF or in the presence of stromal cells from naive orv/v normal goat serum in 0.1% v/v saponin in PBS and incubated
infected B6CD45.2 mice were adoptively transferred into B6CD45.2for 45 min at RT. The following primary reagents were used: rat anti-
mice. Prior to adoptive transfer, DC were pulsed with 200 g/mlER-TR7 (BMA Biomedicals), rat anti-CD68 (clone FA11, Serotec),
chicken egg ovalbumin (OVA, Sigma) for 24 hr and stimulated withrat anti-CD31(cloneMEC 13.3, BD Pharmingen), rat anti-MAdCAM-1
TNF (10 ng/ml) for the last 8 hr of incubation. 3  105 DC were(cloneMECA-367, Serotec), rat anti-CD169 (clone 3D6.112, Serotec),
adoptively transferred intravenously into each mouse. At day 7 afterrat anti-ER-TR9 (BMA Biomedicals), biotinylated rat anti-MHC-II
transfer, thesemice were bled and immunizedwith 200g/mouse of(clone 2G9,BDPharmingen), hamster anti-CD11c (cloneN418, Sero-
either OVA or keyhole limpet hemocyanin (KLH, Sigma) in Completetec), and serum obtained from Leishmania-infected hamsters. After
Freund’s Adjuvant subcutaneously. 1week later, micewere bled andwashing cells four times in 1.5% v/v normal goat serum in 0.1%
boosted with 200 g/mouse of OVA or KLH in Incomplete Freund’sv/v saponin in PBS, specific staining was detected by Alexa 488-
Adjuvant. One week later, mice were sacrificed and blood was col-conjugated goat anti-rat IgG (Molecular Probes) and with Alexa
lected. To determine the capacity of CD4 T cells to transfer toler-546-conjugated goat anti-hamster IgG (Molecular Probes) and
ance, CD4 T cells were isolated from naive mice or mice that hadBODIPY-650 phalloidin to reveal F-actin (Molecular Probes). In some
received OVA-pulsed CD11cloCD45RB DC derived on stromal cellsexperiments, infected cells were also visualized following staining
from infectedmice 1 week earlier. 1 day after receiving 4 106 CD4of nuclei with propidium iodide (30g/ml). Coverslips weremounted
T cells, recipient mice were immunized and boosted, as describedin anti-fade (Molecular Probes) and were visualized with a 63 (NA
above. SerumOVA- or KLH-specific IgG1 and IgG2a antibodieswere1.4) Plan-Apochromat oil immersion objective with a Zeiss Axioplan
detected by using sandwich ELISA. Plates (Nunc) were coated withLSM 510 confocal microscope. Images shown are single optical
50 g/well OVA or KHL in carbonate buffer (pH 9.7) for 1 hr at 37C.slices (0.8–1.0 m).
Wells were blocked with PBS containing 0.05% Tween and 5%milk
powder overnight at 4C. Serum from individual mice was added inAllogeneic Mixed Leukocyte Reaction
serial dilutions in PBS and was incubated for 1 hr at 37C. Biotin-Cell suspensions were made from the spleens of BALB/c mice.
conjugated rat anti-mouse IgG1 and IgG2a antibodies (Serotec)Splenocytes were depleted of CD11c cells bymagnetic cell sorting
were used at 1 or 2 g/ml, respectively, and were incubated for 1 hrby using anti-CD11c magnetic microbeads (Milteneyi Biotec) and a
at 37C for detection of serum IgG1 and IgG2a. To reveal bindingMidiMACS separation column (Milteneyi Biotec). CD4 T cells were
of biotinylated antibodies, plates were incubated for 30 min withsubsequently purified from the CD11c splenocytes by anti-CD4
strepavidin horseradish peroxidase (Serotec). Finally, plates weremagneticmicrobeads (Milteneyi Biotec) and aMidiMACS separation
developed by using a TMB Substrate Reagent Set (BD Pharmingen),column (Milteneyi Biotec) following themanufacturers’ protocol. Pri-
and absorbance was measured at 450 nm by using a microplatemary mixed leukocyte reaction (MLR) were set up in flat-bottom
reader (Molecular Devices).96-well plates (TPP) with 3  105 responder BALB/c CD4 T cells
per well and variable numbers of allogeneic stimulator cells. All
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